Chondroitin sulfate and heparan sulfate glycosaminoglycan chains (CS/HS GAGs)

Chondroitin sulfate (CS) and heparan sulfate (HS) are linear, highly sulfated polysaccharides belonging to the glycosaminoglycan (GAG) family, primarily found as side chains on proteoglycans within the extracellular matrix (ECM) and on cell surfaces [Essentials of Glycobiology, 3rd edition]. These molecules serve as critical regulators of the cellular microenvironment by binding to and modulating the activity of a vast array of proteins, including growth factors, chemokines, and antithrombin [PMID: 21854637]. HS is essential for developmental signaling and blood coagulation, while CS provides structural resilience and lubrication in connective tissues like cartilage [PMID: 11587474]. In pathology, these GAGs are involved in cancer metastasis, where they facilitate tumor cell migration, and in viral infections, where HS often acts as an initial attachment receptor for viruses like HSV and SARS-CoV-2 [PMID: 32869021]. Therapeutic interventions include the use of heparin (a highly sulfated HS variant) as an anticoagulant, HS mimetics to inhibit angiogenesis, and CS supplements for the management of osteoarthritis [NIH NCCIH]. However, targeting these molecules is challenging due to their structural heterogeneity and the potential for off-target effects stemming from their high negative charge density [PMID: 25631230].

Other names

Sulfated glycosaminoglycansCS chainsHS chainsProteoglycan polysaccharide side chainsExtracellular matrix GAGs

Drugs targeting these chains typically act by mimicking their structure to competitively inhibit protein-GAG interactions (HS mimetics), neutralizing their negative charge to reverse anticoagulant effects (protamine), or providing exogenous substrate to support cartilage matrix integrity (chondroitin supplements).